VRTX

Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
$444.28
+4.23 (+0.96%)
Mkt Cap: 112.86B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield2.8%
Dividend YieldN/A
Market Cap112.86B
Volume1.43M
Recent News
Choreo LLC Grows Position in Vertex Pharmaceuticals Incorporated $VRTX
defenseworld.net · 2026-04-14
Trump's Team Says Don't Worry About Rising Inflation. Here Are 3 Stocks to Buy If They're Wrong.
fool.com · 2026-04-14
BIP Wealth LLC Takes $551,000 Position in Vertex Pharmaceuticals Incorporated $VRTX
defenseworld.net · 2026-04-10
Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider
zacks.com · 2026-04-08
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
zacks.com · 2026-04-08
Vertex to Announce First Quarter 2026 Financial Results on May 4th
businesswire.com · 2026-04-06

Unlock the Full Deep Scan

9 AI agents analyze VRTX across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →